Abstract
The thermal stability and thermal decomposition behavior of sodium salts of some penicillins and cephalosporins have been studied using a differential scanning calorimetry technique under a stream of air with a linear heating rate up to 873 K. A “model-free” kinetic method based on the Kissinger equation was applied to decomposition processes of several penicillin and cephalosporin sodium salts to determine activation energy and the pre-exponential factor, following a simplified approach. The values of these parameters referring either to the first or to the slowest decomposition process were used in an attempt to calculate the lifetime for a 1.0% conversion degree of carbenicillin and cephalosporin C, extrapolated at 298.15, 323.15, 373.15 and 423.15 K. Lastly, a comparison of stability data and different calorimetric curve profiles of several antibiotics belonging to the cephalosporin and penicillin classes led to the conclusion that the presence of penicillanic and cephalosporanic rings in all the molecular structures considered does not seem to noticeably affect the overall decomposition mechanisms of the various antibiotics.
Keywords: Activation energy, Cephalosporin salts, Differential scanning calorimetry, Kinetic analysis, Kissinger equation, Penicillin salts, Pre-exponential factor, Storage times, Thermal stability, Kinetic Parameters
Current Pharmaceutical Analysis
Title: A Simplified Approach to Calculating Kinetic Parameters of Thermal Decomposition Processes for Cephalosporin and Penicillin Sodium Salts and to Evaluating their Stabilities
Volume: 7 Issue: 4
Author(s): Stefano Vecchio and Mauro Tomassetti
Affiliation:
Keywords: Activation energy, Cephalosporin salts, Differential scanning calorimetry, Kinetic analysis, Kissinger equation, Penicillin salts, Pre-exponential factor, Storage times, Thermal stability, Kinetic Parameters
Abstract: The thermal stability and thermal decomposition behavior of sodium salts of some penicillins and cephalosporins have been studied using a differential scanning calorimetry technique under a stream of air with a linear heating rate up to 873 K. A “model-free” kinetic method based on the Kissinger equation was applied to decomposition processes of several penicillin and cephalosporin sodium salts to determine activation energy and the pre-exponential factor, following a simplified approach. The values of these parameters referring either to the first or to the slowest decomposition process were used in an attempt to calculate the lifetime for a 1.0% conversion degree of carbenicillin and cephalosporin C, extrapolated at 298.15, 323.15, 373.15 and 423.15 K. Lastly, a comparison of stability data and different calorimetric curve profiles of several antibiotics belonging to the cephalosporin and penicillin classes led to the conclusion that the presence of penicillanic and cephalosporanic rings in all the molecular structures considered does not seem to noticeably affect the overall decomposition mechanisms of the various antibiotics.
Export Options
About this article
Cite this article as:
Vecchio Stefano and Tomassetti Mauro, A Simplified Approach to Calculating Kinetic Parameters of Thermal Decomposition Processes for Cephalosporin and Penicillin Sodium Salts and to Evaluating their Stabilities, Current Pharmaceutical Analysis 2011; 7 (4) . https://dx.doi.org/10.2174/157341211797457961
DOI https://dx.doi.org/10.2174/157341211797457961 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Association of High Levels of Spot Urine Protein with High Blood Pressure, Mean Arterial Pressure and Pulse Pressure with the Development of Diabetic Chronic Kidney Dysfunction or Failure among Diabetic Patients. Statistical Regression Modeling to Predict Diabetic Proteinuria
Current Diabetes Reviews Cardiovascular Effects of Neuregulin-1/ErbB Signaling: Role in Vascular Signaling and Angiogenesis
Current Pharmaceutical Design Hepatic Diseases Related to Triglyceride Metabolism
Mini-Reviews in Medicinal Chemistry Clinical Experience with Specific COX-2 Inhibitors in Arthritis
Current Pharmaceutical Design Statins and Solid Organ Transplantation
Current Pharmaceutical Design Unusual Food Allergy: AlioideaAllergic Reactions Overview
Recent Patents on Inflammation & Allergy Drug Discovery CD38 as a Regulator of Cellular NAD: A Novel Potential Pharmacological Target for Metabolic Conditions
Current Pharmaceutical Design Pharmacological Approaches of Alzheimer's Disease: An Update
Current Drug Therapy Increased Salt Sensitivity in Obese Hypertension: Role of the Sympathetic Nervous System
Current Hypertension Reviews Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury
Current Pharmaceutical Biotechnology Pericyte Loss in Diabetic Retinopathy: Mechanisms and Consequences
Current Medicinal Chemistry Oxidative Stress and the Pathogenesis of Atrial Fibrillation
Current Cardiology Reviews Diabetes Mellitus Type 2 and Functional Foods of Plant Origin
Recent Patents on Biotechnology Beneficial Effects of Sildenafil on Tissue Perfusion and Inflammation in a Murine Model of Limb Ischemia and Atherosclerosis
Current Vascular Pharmacology Use of Double-source Computed Tomography for Evaluation of the Relationship Between Smoking and Coronary Plaques
Current Medical Imaging Indications, Implications and Applications of Renal Denervation. Have we Discovered Something new?
Current Hypertension Reviews A Validated UPLC Method Used for the Determination of Trandolapril and its Degradation Products as per ICH Guidelines
Current Pharmaceutical Analysis Current Pharmaceutical Design on Adhesive Based Transdermal Drug Delivery Systems
Current Pharmaceutical Design Lipid Mediator Profiling in Pulmonary Disease
Current Pharmaceutical Biotechnology Nanoparticle Based Treatment for Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets